Nord/LB Analysts Give Draegerwerk AG & Co KGaA (ETR:DRW3) a €45.00 Price Target

Nord/LB set a €45.00 ($52.33) price objective on Draegerwerk AG & Co KGaA (ETR:DRW3) in a report published on Friday, Borsen Zeitung reports. The brokerage currently has a sell rating on the stock.

DRW3 has been the topic of a number of other reports. Warburg Research set a €49.00 ($56.98) price objective on shares of Draegerwerk AG & Co KGaA and gave the company a neutral rating in a research note on Wednesday, October 16th. Independent Research set a €52.00 ($60.47) target price on shares of Draegerwerk AG & Co KGaA and gave the company a sell rating in a research report on Tuesday, November 19th. Hauck & Aufhaeuser set a €38.00 ($44.19) target price on shares of Draegerwerk AG & Co KGaA and gave the company a sell rating in a research report on Tuesday, November 19th. HSBC set a €50.00 ($58.14) price target on Draegerwerk AG & Co KGaA and gave the company a neutral rating in a research note on Tuesday, November 5th. Finally, Deutsche Bank set a €46.00 ($53.49) price target on Draegerwerk AG & Co KGaA and gave the stock a neutral rating in a research report on Wednesday, August 14th. Four equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the company. The stock currently has a consensus rating of Sell and an average target price of €46.14 ($53.65).

DRW3 opened at €54.15 ($62.97) on Friday. The firm has a 50 day simple moving average of €55.04 and a 200 day simple moving average of €49.60. Draegerwerk AG & Co KGaA has a fifty-two week low of €38.32 ($44.56) and a fifty-two week high of €59.40 ($69.07). The company has a market cap of $411.54 million and a price-to-earnings ratio of 37.45. The company has a debt-to-equity ratio of 31.33, a current ratio of 1.93 and a quick ratio of 1.09.

About Draegerwerk AG & Co KGaA

Drägerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Featured Story: Are 12b-1 Fees Affecting Your Mutual Fund Performance?

Analyst Recommendations for Draegerwerk AG & Co KGaA (ETR:DRW3)

Receive News & Ratings for Draegerwerk AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Draegerwerk AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.